AI IntelligenceJul 24, 2026Primary Market
Article
Biotech AI Startup (aus Top-10-Runden) · $95M · Series B
A biotech company focused on AI-driven drug discovery has secured $95 million in Series B funding. The capital will advance the preclinical development of several pipeline candidates. The round shows investor confidence in AI's ability to revolutionize the drug research process.
Data Cube AI EditorialSource: Crunchbase News
01
Source Brief
A biotech company focused on AI-driven drug discovery has secured $95 million in Series B funding. The capital will advance the preclinical development of several pipeline candidates. The round shows investor confidence in AI's ability to revolutionize the drug research process.